NexImmune Inc logo

NexImmune Inc

$ 0.39 -0.0223 (-5.47%) 10:08 PM EST
P/E:
At Loss
P/B:
0.21
Market Cap:
$ 10.04M
Enterprise V:
$ -34.07M
Volume:
70.41K
Avg Vol (2M):
157.93K
Also Trade In:
Volume:
70.41K
Market Cap $:
10.04M
PE Ratio:
At Loss
Avg Vol (2-Month):
157.93K
Enterprise Value $:
-34.07M
PB Ratio:
0.21
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
Name Current Vs Industry Vs History
Cash-To-Debt 39.53
Equity-to-Asset 0.83
Debt-to-Equity 0.02
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -22.2
3-Year EPS without NRI Growth Rate -18.5
3-Year FCF Growth Rate -24.6

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 16.69
9-Day RSI 23.23
14-Day RSI 27.21
6-1 Month Momentum % -73.82
12-1 Month Momentum % -90.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.54
Quick Ratio 5.54
Cash Ratio 4.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -32.7
Name Current Vs Industry Vs History
ROE % -86.15
ROA % -76.96
ROIC % -1005.97
ROC (Joel Greenblatt) % -1155.62
ROCE % -85.63

Financials (Next Earnings Date:2023-03-09 Est.)

NEXI's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:NEXI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -4.49
Beta 0
Volatility % 124.75
14-Day RSI 27.21
14-Day ATR ($) 0.048621
20-Day SMA ($) 0.454455
12-1 Month Momentum % -90.71
52-Week Range ($) 0.3648 - 7.13
Shares Outstanding (Mil) 26.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NexImmune Inc Filings

Document Form Filing Date
No Filing Data

NexImmune Inc Analysis

Share your research

Headlines

See More
No news.